Profile
Mark Wingertzahn is currently an Associate Professor at the New York Institute of Technology, a Vice President-Research & Development at GlaxoSmithKline, Inc., the Head-Global Clinical Research at Pfizer Consumer Healthcare, and the Chief Scientific Officer at Wesana Health Holdings, Inc. He previously worked as the Head-Development and SVP-Research & Development at Kaleido Biosciences, Inc.
Mark Wingertzahn active positions
| Companies | Position | Start |
|---|---|---|
| WESANA HEALTH HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 21/05/2021 |
New York Institute of Technology
New York Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Pfizer Consumer Healthcare
Pfizer Consumer Healthcare Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Former positions of Mark Wingertzahn
| Companies | Position | End |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
New York Institute of Technology
New York Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Pfizer Consumer Healthcare
Pfizer Consumer Healthcare Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Wesana Health Holdings, Inc.
Wesana Health Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of drug therapies using high dose psilocybin-assisted psychotherapy and formulations | Health Technology |
- Stock Market
- Insiders
- Mark Wingertzahn
















